Spectrum of Steroid-Resistant and Congenital Nephrotic Syndrome in Children
Top Cited Papers
- 1 April 2015
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 10 (4), 592-600
- https://doi.org/10.2215/cjn.06260614
Abstract
Background and objectives Steroid-resistant nephrotic syndrome is a rare kidney disease involving either immune-mediated or genetic alterations of podocyte structure and function. The rare nature, heterogeneity, and slow evolution of the disorder are major obstacles to systematic genotype-phenotype, intervention, and outcome studies, hampering the development of evidence-based diagnostic and therapeutic concepts. To overcome these limitations, the PodoNet Consortium has created an international registry for congenital nephrotic syndrome and childhood-onset steroid-resistant nephrotic syndrome. Design, setting, participants, & measurements Since August of 2009, clinical, biochemical, genetic, and histopathologic information was collected both retrospectively and prospectively from 1655 patients with childhood-onset steroid-resistant nephrotic syndrome, congenital nephrotic syndrome, or persistent subnephrotic proteinuria of likely genetic origin at 67 centers in 21 countries through an online portal. Results Steroid-resistant nephrotic syndrome manifested in the first 5 years of life in 64% of the patients. Congenital nephrotic syndrome accounted for 6% of all patients. Extrarenal abnormalities were reported in 17% of patients. The most common histopathologic diagnoses were FSGS (56%), minimal change nephropathy (21%), and mesangioproliferative GN (12%). Mutation screening was performed in 1174 patients, and a genetic disease cause was identified in 23.6% of the screened patients. Among 14 genes with reported mutations, abnormalities in NPHS2 (n=138), WT1 (n=48), and NPHS1 (n=41) were most commonly identified. The proportion of patients with a genetic disease cause decreased with increasing manifestation age: from 66% in congenital nephrotic syndrome to 15%–16% in schoolchildren and adolescents. Among various intensified immunosuppressive therapy protocols, calcineurin inhibitors and rituximab yielded consistently high response rates, with 40%–45% of patients achieving complete remission. Confirmation of a genetic diagnosis but not the histopathologic disease type was strongly predictive of intensified immunosuppressive therapy responsiveness. Post-transplant disease recurrence was noted in 25.8% of patients without compared with 4.5% (n=4) of patients with a genetic diagnosis. Conclusions The PodoNet cohort may serve as a source of reference for future clinical and genetic research in this rare but significant kidney disease.Keywords
This publication has 26 references indexed in Scilit:
- Steroid-resistant idiopathic nephrotic syndrome in children: long-term follow-up and risk factors for end-stage renal diseaseBrazilian Journal of Nephrology, 2013
- Nephrotic Syndrome in the First Year of Life: Two Thirds of Cases Are Caused by Mutations in 4 Genes (NPHS1, NPHS2, WT1, and LAMB2)PEDIATRICS, 2007
- Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreatedNephrology Dialysis Transplantation, 2007
- Steroid-resistant nephrotic syndrome: the influence of race on cyclophosphamide sensitivityPediatric Nephrology, 2006
- Experience of renal biopsy in children with nephrotic syndromePediatric Nephrology, 2005
- High incidence of initial and late steroid resistance in childhood nephrotic syndromeKidney International, 2005
- Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic SyndromeJournal of the American Society of Nephrology, 2004
- Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UKPediatric Nephrology, 2001
- Changing patterns in the histopathology of idiopathic nephrotic syndrome in childrenKidney International, 1999
- High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhoodPediatric Nephrology, 1999